Alterity Therapeutics (ATHE) Presents Positive Phase 2 Data for ATH434
Alterity Therapeutics Limited (NASDAQ:ATHE) is one of the best performing ASX stocks in 2025.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 20,077 | $71,474 | +20% | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 62,000 | $332,940 | 0% | |
| 2. | 58,460 | $313,930 | 0% | |
| 3. | 2,309 | $12,399 | 0% | |
| 4. | 40 | $215 | 0% | |
| 5. | 39 | $205 | 0% |